Research Article
Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis
Table 2
Association between and clinical variables in AR patients.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
AR: allergic rhinitis; BMI: body mass index; VAS: visual analogue scales; TNSS: total nasal symptoms score; MMP-12: matrix metalloproteinase-12; MRGPRX2: mas-related G protein-coupled receptor-X2. |